TRIBUTE - A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

TRIBUTE - A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC)

Published:2004-07-15 Issue:14_suppl Volume:22 Page:7011-7011
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Herbst R. S.¹,Prager D.¹,Hermann R.¹,Miller V.¹,Fehrenbacher L.¹,Hoffman P.¹,Johnson B.¹,Sandler A. B.¹,Mass R.¹,Johnson D. H.¹

Affiliation:

1. U Texas M. D. Anderson Cancer Ctr, Houston, TX; UCLA Medical Center, Los Angeles, CA; NW Georgia Oncology Centers, Marietta, GA; Memorial Sloan-Kettering Cancer Center, New York, NY; Kaiser Permanente Medical Center, Vallejo, CA; University of Chicago Hospital, Chicago, IL; Dana Farber Cancer Institute, Boston, MA; Vanderbilt-Ingram Cancer Center, Nashville, TN; Genentech, South San Francisco, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.7011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized Phase II Designs;Bayesian Adaptive Design for Immunotherapy and Targeted Therapy;2023

2. A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320;International Journal of Radiation Oncology*Biology*Physics;2013-04

3. Targeting Signaling Pathways in Cancer Therapy;From Local Invasion to Metastatic Cancer;2009

4. Targeting Small Molecules in Cancer;Cancer Metastasis And The Lymphovascular System: Basis For Rational Therapy;2007

5. Non‐Small‐Cell Lung Cancer;Wiley Handbook of Current and Emerging Drug Therapies;2006-09-15